Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Quality of life in lung cancer patients
Autore:
Gridelli, C; Perrone, F; Nelli, F; Ramponi, S; De Marinis, F;
Indirizzi:
Ist Nazl Tumori, Div Oncol Med B, I-80131 Naples, Italy Ist Nazl Tumori Naples Italy I-80131 Oncol Med B, I-80131 Naples, Italy Ist Nazl Napoli, Ufficio Sperimentaz Clin Controllate, Naples, Italy Ist Nazl Napoli Naples Italy perimentaz Clin Controllate, Naples, Italy Osped Camillo Forlanini, Unita Pneumol 5, Rome, Italy Osped Camillo Forlanini Rome Italy lanini, Unita Pneumol 5, Rome, Italy
Titolo Testata:
ANNALS OF ONCOLOGY
, volume: 12, anno: 2001, supplemento:, 3
pagine: S21 - S25
SICI:
0923-7534(2001)12:<S21:QOLILC>2.0.ZU;2-R
Fonte:
ISI
Lingua:
ENG
Soggetto:
RANDOMIZED PHASE-III; OF-LIFE; SUPPORTIVE CARE; ORAL ETOPOSIDE; CHEMOTHERAPY; CISPLATIN; TRIAL; MULTICENTER; SURVIVAL; IFOSFAMIDE;
Keywords:
non-small-cell lung cancer; quality of life; small-cell lung cancer;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
24
Recensione:
Indirizzi per estratti:
Indirizzo: Gridelli, C Ist Nazl Tumori, Div Oncol Med B, Via M Semmola, I-80131 Naples, Italy Ist Nazl Tumori Via M Semmola Naples Italy I-80131 les, Italy
Citazione:
C. Gridelli et al., "Quality of life in lung cancer patients", ANN ONCOL, 12, 2001, pp. S21-S25

Abstract

The quality of life of lung cancer patients is affected by several factorsrelated to the patients, stage of disease and treatment characteristics. For small-cell lung cancer (SCLC), the treatment is generally aggressive, primarily based on chemotherapy. Treatment strategy for non-small-cell lung cancer (NSCLC) is strongly dependent on the stage of the disease and ranges from surgery to palliative chemotherapy. Over the last few years, very little progress has been made in terms of survival. Therefore, the effect of treatment on quality of life has become progressively more relevant. Among the instruments for measuring quality of life, there are some specifically developed for lung cancer, such as the European Organization for Research andTreatment of Cancer (EORTC) LC-13 questionnaire, the Functional Assessmentof Cancer Therapy (FACT-L) questionnaire and the Lung Cancer Symptom Scale(LCSS). Up to now, few randomised clinical trials have correctly evaluatedquality of life. There are evident pitfalls associated with the use of frequently non-validated tools, and poor methods of data analysis, but quality-of-life evaluation is crucial and should be addressed through well-plannedand well-conducted prospective clinical trials.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/03/20 alle ore 14:13:47